Retatrutide does not yet have dedicated cardiovascular or renal outcome trials, though Phase 3 studies evaluating these endpoints are currently enrolling participants with expected completion in 2026
Preparing for PDURS The company is preparing the New Expected Prescription Drug Use-Related Software (PDURS) Model, expected to be finalized later this year
GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom GLP-1 Drugs GLP-1 Drugs Distribution Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering
The peptide reconstitution calculator on SeekPeptides can walk you through these calculations for any vial size and water volume combination
Cng thc ha hc ca GLP-1 l C165H264N50O55S2, khi lng mol khong 3,8 kDa v CAS 87805-34-3
Main Multi-Target GLP-1 Innovative Drug Pipelines Similarly, there are currently about 35 main pipelines for multi-target GLP-1 innovative drugs
